Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Elephantiasis (Lymphatic Filariasis) - Overview
Elephantiasis (Lymphatic Filariasis) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Elephantiasis (Lymphatic Filariasis) - Therapeutics Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Elephantiasis (Lymphatic Filariasis) - Companies Involved in Therapeutics Development
AbbVie Inc
Ebelle Pharmaceuticals Inc
Eisai Co Ltd
Medicines Development Ltd
Pai Life Sciences Inc
Elephantiasis (Lymphatic Filariasis) - Drug Profiles
ABBV-4083 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AWZ-1066S - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EDE-1206 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
filariasis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lymphatic filariasis (multivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lymphatic filariasis (multivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
moxidectin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Elephantiasis (Lymphatic Filariasis) - Dormant Projects
Elephantiasis (Lymphatic Filariasis) - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development for Elephantiasis (Lymphatic Filariasis), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development for Elephantiasis (Lymphatic Filariasis), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Elephantiasis (Lymphatic Filariasis) - Pipeline by AbbVie Inc, H1 2020
Elephantiasis (Lymphatic Filariasis) - Pipeline by Ebelle Pharmaceuticals Inc, H1 2020
Elephantiasis (Lymphatic Filariasis) - Pipeline by Eisai Co Ltd, H1 2020
Elephantiasis (Lymphatic Filariasis) - Pipeline by Medicines Development Ltd, H1 2020
Elephantiasis (Lymphatic Filariasis) - Pipeline by Pai Life Sciences Inc, H1 2020
Elephantiasis (Lymphatic Filariasis) - Dormant Projects, H1 2020